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EDITORIAL
Missing a malignancy is a significant concern for paediatricians. It potentially leads to delay in treatment and impacts negatively on the doctor-patient/family relationship. Acute lymphoblastic leukaemia (ALL) is the commonest cancer in childhood affecting around 4 per 100,000 children per year. Brix et al, in this month's Archives, present a retrospective cohort of 286 patients with ALL diagnosed over two decades at two centres in Denmark.(1) They highlight the frequent presence of musculoskeletal (MSK) symptoms and signs amongst newly-diagnosed children, in particular 18.5% with localised joint pain of whom half had objective signs of arthritis. Other studies also suggest that MSK, and particularly joint, involvement is relatively common in ALL at around 10-20%. However, the probability of any given child presenting with MSK symptoms having ALL remains very low. whether before initial presentation to health professionals or after first evaluation.
Reassuringly, the long term follow-up data demonstrate that the group of ALL patients with joint involvement at presentation had significantly better event-free and overall 5-year survival compared with the group without. The latter, however, included a higher proportion of T cell ALL which had a poorer outcome during the 1992-2013 period and explains the significant difference in outcomes. It would be interesting for future studies to focus on ALL subtypes and leukaemia genetics: do certain forms present more commonly with joint symptoms which also have better survival outcomes?
What can be done to avoid misdiagnosis of children with arthralgia or arthritis? The first step is always to consider malignancy in the differential diagnosis and remain alert for clinical features which do not fit an expected pattern. More typical features of ALL such as fever, fatigue, bruising and bleeding must prompt further investigation, although this study highlights that constitutional features and bleeding were less common in the group with joint manifestations at presentation compared to those without (55% vs 81% and 10% vs 43% respectively). commencing treatment. We suggest that the standard practice should be definitive investigation with diagnostic bone marrow aspiration in these select cases unless there is a strong reason not to do so.
